Deep learning derived mechanical biomarkers for cancer therapy prediction

This project aims to develop a deep learning-based biomarker using ultrasound elastography to predict and monitor cancer treatment responses, particularly targeting tumor stiffness in sarcoma patients.

Subsidie
€ 150.000
2022

Projectdetails

Introduction

In the fight against cancer, it is well recognized that tumors are highly heterogeneous and they might differ considerably not only between tumor types but also among tumors of the same type or even for the same tumor during progression. As a result, the efficacy of standard cancer therapies varies, and while some patients respond to a particular treatment, other patients do not gain any benefit. Consequently, crucial in cancer therapy is the prediction of a patient’s response to treatment.

Background

Failure of standard therapies has led to the introduction of a new era of personalized, patient-specific treatments, which are based on the identification of biomarkers that characterize the state of a particular tumor. Many solid tumors (e.g., breast cancers and sarcomas) stiffen as they grow in a host’s normal tissue. Tumor stiffening is a known factor leading to compromised efficacy of therapeutics.

Recent Developments

Recently, it has been demonstrated by our team and co-workers that repurposing of common drugs with anti-fibrotic properties, known as “mechanotherapeutics,” target tumor stiffness and enhance therapy. Here, we aim to harness the power of deep learning (DL) methods in order to develop a robust biomarker based on ultrasound shear wave elastography (SWE).

Objectives

This biomarker will aim to:

  1. Predict patient’s response to treatment, separating responders and non-responders.
  2. Monitor treatment outcomes, in the case of strategies that target tumor stiffness (i.e., mechanotherapeutics).

Methodology

The DL algorithms will be applied to a large set of existing preclinical data and to additional new data. A proof of concept clinical study on sarcoma patients will accommodate the clinical translation of the biomarker.

Commercialization

Furthermore, we propose to develop a software product to be used as a commercial tool for the measurement of the DL-derived, SWE biomarker. A planned market research will highlight the best options for commercialization.

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 150.000
Totale projectbegroting€ 150.000

Tijdlijn

Startdatum1-9-2022
Einddatum29-2-2024
Subsidiejaar2022

Partners & Locaties

Projectpartners

  • UNIVERSITY OF CYPRUSpenvoerder

Land(en)

Geen landeninformatie beschikbaar

Vergelijkbare projecten binnen European Research Council

ERC STG

MANUNKIND: Determinants and Dynamics of Collaborative Exploitation

This project aims to develop a game theoretic framework to analyze the psychological and strategic dynamics of collaborative exploitation, informing policies to combat modern slavery.

€ 1.497.749
ERC STG

Elucidating the phenotypic convergence of proliferation reduction under growth-induced pressure

The UnderPressure project aims to investigate how mechanical constraints from 3D crowding affect cell proliferation and signaling in various organisms, with potential applications in reducing cancer chemoresistance.

€ 1.498.280
ERC STG

The Ethics of Loneliness and Sociability

This project aims to develop a normative theory of loneliness by analyzing ethical responsibilities of individuals and societies to prevent and alleviate loneliness, establishing a new philosophical sub-field.

€ 1.025.860
ERC STG

Uncovering the mechanisms of action of an antiviral bacterium

This project aims to uncover the mechanisms behind Wolbachia's antiviral protection in insects and develop tools for studying symbiont gene function.

€ 1.500.000

Vergelijkbare projecten uit andere regelingen

ERC ADG

Mechanobiology of cancer progression

This project aims to develop an innovative in vivo platform to study tumor fibrosis and improve targeted cancer therapies by mimicking the fibrotic microenvironment of breast cancer.

€ 2.498.690
ERC STG

Mechano-modulation of tumor microenvironment with mechanotherapeutics and sonopermeation to optimize nano-immunotherapy

This project aims to enhance drug delivery and treatment efficacy in desmoplastic tumors by synergistically combining mechanotherapeutics and ultrasound sonopermeation, supported by computational modeling.

€ 1.500.000
ERC STG

Personalised Mechanobiological Models to Predict Tumour Growth and Anti-Cancer Drug Penetration

This project aims to develop a personalized cancer treatment framework by modeling stress-dependent tumor growth and drug penetration to enhance patient-specific therapy outcomes.

€ 1.499.693
ERC STG

Advanced analysis of multiparametric volumetric ultrafast ultrasound: a novel approach for non-invasive breast cancer diagnosis

This project aims to enhance non-invasive breast cancer diagnosis by integrating machine learning with advanced ultrasound techniques to create predictive models for tumor characteristics, reducing reliance on biopsies.

€ 1.499.498